New name reflects ongoing commitment to supporting the life science community by LaunchWorks.
LaunchWorks Manufacturing Lab, a company serving the life science market, is now LaunchWorks CDMO (Contract Development and Manufacturing Organization). Launchworks recently received their ISO 13485 as a CDMO. Accompanying this new capability, the company has revamped its website and reimagined a logo design consistent with other divisions of its parent company Integreon Global.
Originally formed within Enzymatics in 2009, LaunchWorks has evolved over the past 10 years to become an ISO 13485 certified company that is FDA Registered. Integreon Global acquired LaunchWorks in 2017, and has since worked to add new service offerings, including embarking on an automation program designed to help its customers be more competitive. Recently, a significant portion of the company’s efforts have revolved around the response to the COVID-19 crisis.
“The enhancement of our services is an important step in showcasing our commitment to deliver a comprehensive scope of capabilities, to support our clients’ path to commercialization. Our service offerings are designed to meet each customer’s unique set of challenges,” says Jeff Kelly, General Manager of LaunchWorks CDMO. “This is a crucial step as we expand our ability to support the world’s changing needs due to the pandemic, as well as incorporate automation and device manufacturing. Launchworks, with our service suite ranging from package design to fulfillment and technologies, is uniquely positioned to meet the challenge of helping companies translate their science into commercial products, thereby contributing to the improvement in world health.”
For more information visit www.launchworkscdmo.com.